medline.ch Onkologie Urologische Tumoren
Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 18. Mai 2022
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7300  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 145996  
   
Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia.
Int J Cancer
Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, Gunter MJ, Holmes MV, Martin RM, Tsilidis KK, Albanes D, Barricarte A, Bueno-de-Mesquita HB, Chen C, Cohn BA, Dimou NL, Ferrucci L, Flicker L, Freedman ND, Giles GG, Giovannucci EL, Goodman GE, Haiman CA, Hankey GJ, Huang J, Huang WY, Hurwitz LM, Kaaks R, Knekt P, Kubo T, Langseth H, Laughlin G, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Mikami K, Mucci LA, Olsen AW, Ozasa K, Palli D, Penney KL, Platz EA, Rissanen H, Sawada N, Schenk JM, Stattin P, Tamakoshi A, Thysell E, Tsai CJ, Tsugane S, Vatten L, Weiderpass E, Weinstein SJ, Wilkens LR, Yeap BB, PRACTICAL consortium, CRUK, BPC3, CAPS, PEGASUS., Allen NE, Key TJ, Travis RC.
PMID: 35579976 [PubMed - as supplied by publisher]


Ultra-high-field MR in Prostate cancer: Feasibility and Potential.
MAGMA
Tenbergen CJA, Metzger GJ, Scheenen TWJ.
PMID: 35579785 [PubMed - as supplied by publisher]


[Failure patterns following external beam radiotherapy with or without additional focal boost in the randomized FLAME trial for localized prostate cancer].
Strahlenther Onkol
Spohn SKB, Grosu AL.
PMID: 35579679 [PubMed - as supplied by publisher]


Recent clinical trial data of androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.
Clin Adv Hematol Oncol
Beltran H.
PMID: 35579578 [PubMed - as supplied by publisher]


Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.
Clin Adv Hematol Oncol
Rettig MB, Beltran H, Oh WK.
PMID: 35579577 [PubMed - as supplied by publisher]


Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins.
Abdom Radiol (NY)
Quentin M, Schimmöller L, Ullrich T, Valentin B, Demetrescu D, Al-Monajjed R, Mally D, Esposito I, Albers P, Antoch G, Arsov C.
PMID: 35578110 [PubMed - as supplied by publisher]


Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.
Eur Urol Focus
Geboers B, Gondoputro W, Thompson JE, Reesink DJ, van Riel LAMJG, Zhang D, Blazevski A, Doan P, Agrawal S, Matthews J, Haynes AM, Liu Z, Delprado W, Shnier R, de Reijke TM, Lawrentschuk N, Stijns PEF, Yaxley JW, Scheltema MJ, Stricker PD.
PMID: 35577751 [PubMed - as supplied by publisher]


T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Eur Urol Focus
Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, , Bauerová L, Pe, Maxim Bruins H, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Mertens LS, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, A L M Kiemeney L, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG.
PMID: 35577750 [PubMed - as supplied by publisher]


Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002.
Eur Urol Oncol
Guler OC, Onal C.
PMID: 35577749 [PubMed - as supplied by publisher]


Physical Activity in Patients With Kidney Cancer: A Scoping Review.
Clin Genitourin Cancer
Arthuso FZ, Courneya KS.
PMID: 35577733 [PubMed - as supplied by publisher]


[Comparison of systematic, targeted and combined prostate biopsies for the diagnosis of prostate cancer with MRI lesion].
Prog Urol
Gander J, Guandalino M, Vedrine N, Charbonnel C, Gayrel P, Ceruti F, Guy L.
PMID: 35577670 [PubMed - as supplied by publisher]


Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
Eur Urol
Szabados B, Kockx M, Assaf ZJ, van Dam PJ, Rodriguez-Vida A, Duran I, Crabb SJ, Van Der Heijden MS, Pous AF, Gravis G, Herranz UA, Protheroe A, Ravaud A, Maillet D, Mendez MJ, Suarez C, Linch M, Prendergast A, Tyson C, Stanoeva D, Daelemans S, Rombouts M, Mariathasan S, Tea JS, Mousa K, Sharma S, Aleshin A, Banchereau R, Castellano D, Powles T.
PMID: 35577646 [PubMed - as supplied by publisher]


Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial.
Eur Urol
Hall E, Hussain SA, Porta N, Lewis R, Crundwell M, Jenkins P, Rawlings C, Tremlett J, Sreenivasan T, Wallace J, Syndikus I, Sheehan D, Lydon A, Huddart R, James N, BC2001 Investigators..
PMID: 35577644 [PubMed - as supplied by publisher]


Telaglenastat Plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 ENTRATA Trial.
Clin Cancer Res
Lee CH, Motzer R, Emamekhoo H, Matrana M, Percent I, Hsieh JJ, Hussain A, Vaishampayan U, Liu S, McCune S, Patel V, Shaheen M, Bendell J, Fan AC, Gartrell BA, Goodman OB, Nikolinakos PG, Kalebasty AR, Zakharia Y, Zhang Z, Parmar H, Akella L, Orford K, Tannir NM.
PMID: 35576438 [PubMed - as supplied by publisher]


Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer.
Curr Oncol Rep
Tulpule V, Morrison GJ, Falcone M, Quinn DI, Goldkorn A.
PMID: 35575959 [PubMed - as supplied by publisher]


Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study.
Scand J Urol
Wang EYH, Pihlström N, Malmström PU, Gårdmark T.
PMID: 35575423 [PubMed - as supplied by publisher]


Identifying homogeneous healthcare use profiles and treatment sequences by combining sequence pattern mining with care trajectory clustering in kidney cancer patients on oral anticancer drugs: A case study.
Health Informatics J
Baudrier C, Tran Y, Delanoy N, Katsahian S, Sabatier B, Perrin G.
PMID: 35575035 [PubMed - in process]


Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Non-muscle Invasive Bladder Cancer.
J Urol
Kates M, Mansour AM, Lamm DL, Shore N, Maulhardt H, Wendt A, Verco J, Marin A, Dewnani K, Verco S, diZerega GS.
PMID: 35574612 [PubMed - as supplied by publisher]


A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
Front Oncol
Jo H, Hong J, Kim H, Kim HR, Kwon GY, Kang KA, Park SY, Kim CK, Park BK, Chung JH, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH.
PMID: 35574412 [PubMed]


Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer.
Front Oncol
Yang P, Qiao Y, Meng M, Zhou Q.
PMID: 35574342 [PubMed]


   
   Artikel 1 - 20 / 145996    Seite 1 von 7300  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1